EPL Limited receives no-objection letters from BSE and NSE for Scheme of Amalgamation
EPL Ltd · Industrial Products
What the filing says
- EPL filed a draft scheme for amalgamation of Indovida India Private Limited with EPL under Sections 230-232 of Companies Act, 2013.
- Both BSE and NSE issued observation letters dated October 19, 2026, conveying no adverse observations and no objection to filing the scheme with NCLT.
- The observation letters specify compliance requirements including disclosure obligations, no changes without regulatory consent, and submission deadlines within six months from October 19, 2026.
Why it's rated notable: merger demerger is always high
Figures checked against the filing by a second AI read. About the business, not the share price.
Original filing
Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other acquisition / merger filings this fortnight
- Sudarshan Europe B.V. discloses substantial acquisition in Heubach Colorants India Ltd
- Sagility Limited acquires Chirok Health to expand provider-focused services
- Dr. Agarwal’s Eye Hospital Ltd approves Scheme of Amalgamation effective Nov 1, 2026
- Shrem InvIT manager's board approves up to INR 1,046 crore NaBFID term loan
- Dr. Agarwal's Health Care board notes amalgamation scheme effective Nov 1, 2026
- Kwality Pharmaceuticals acquires 4 acres for manufacturing expansion in Amritsar
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.